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Abstract
Background: Candida albicans is one of the organisms living on the human body symbiotically, but, in hosts with
low immunity it becomes one of the most pathogenic fungal organisms. Combretum zeyheri has been reported to
have antifungal, antibacterial and antioxidant activities. Medicinal plants are believed to be non-toxic by the general
public. Toxicity studies, however, have indicated that they are capable of causing numerous side effects, therefore,
evaluation of safety is required. The objective of this study was to determine the toxicity of the antifungal
constituents of Combretum zeyheri on mammalian cells.
Methods: Alkaloids, saponins, flavonoids-enriched extracts and crude ethanol extracts were prepared from the
leaves of Combretum zeyheri. The broth microdilution method was used to investigate for antifungal activity, with
miconazole used as the positive control. The MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide)
assay was used to determine cell viability of the Candida albicans cells. The most potent extracts; the ethanol
extract, alkaloids and saponins respectively, were further tested for their toxicity on sheep erythrocytes, mouse
peritoneal macrophages and Jurkat T cells.
Results: All Combretum zeyheri extracts displayed a dose-dependent antifungal activity and had IC50 values ranging
from 16 μg/ml to 159 μg/ml for Candida albicans. The alkaloids, saponins and ethanol extracts were found to be
non-toxic towards mouse peritoneal cells and Jurkat T cells. In the haemolysis assay, all extracts were haemolytic
at varying degrees and showed their greatest haemolytic activity at the highest concentration of 5 mg/ml. The
saponins were the least haemolytic, followed by the ethanol extracts and the alkaloids respectively. Although these
extracts were haemolytic to some extent, they may considered safe at therapeutic concentrations since there was
a large difference between the antifungal IC50 and haemolysis EC50 values, hence a large therapeutic window.
Conclusions: Combretum zeyheri antifungal constituents are, therefore, a potential source of lead compounds
which can be developed into antifungal drugs of natural origin owing to Combretum zeyheri’s effective antifungal
activity and low toxicity to mammalian cells.
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Background
Pathogenic fungi cause infections leading to critical
threats on public health. The sudden uprising of fungal
infections in the last few years is attributed to the
population’s susceptibility to opportunistic infections
precipitated by immune system suppression closely
linked to malnutrition [1]. Candida albicans is one of
the organisms living on the human body symbiotically,
but, in hosts with low immunity it is one of the resilient
fungal organisms [2]. Candida albicans causes a number
of non-life threatening conditions including vaginitis and
oral thrush [3]. The fungi can also pass through the
blood stream and may affect systemic organs including
heart valves and this may be fatal especially in immuno-
compromised individuals [4].
The emergence of mutant pathogenic strains that are
resistant to current drugs, necessitates the need to find
new, safe and effective drug compounds with minimum
or acceptable side effects [4]. There are few effective an-
tifungals available and most of them have unpleasant
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effects such as renal toxicity that occurs during the use
of amphotericin B, and drug-drug interactions in the use
of azoles [5]. The prevalence of fungal infections is in-
creased by antibiotic resistance and antifungal drug tox-
icity especially after prolonged treatment, hence, there is
need for new, safe and non-toxic drugs [1].
The World Health Organisation reports that greater
than 80 % of the world’s population relies on traditional
medicine to cater for primary health care [1]. Herbal
medicines are believed to be free from side effects, less
toxic and cheaper than conventional medicines. How-
ever, the cytotoxicity of plants-derived medicinal prod-
ucts has to be investigated [6]. A number of synthetic
drugs were developed through mimicking the structures
of compounds isolated from plants [7]. It is important
to gain knowledge on the chemical constituents from
plants to enable therapeutic agent discovery and
unmasking other sources of such chemicals. Drugs
from natural sources exhibit drug likeness and bio-
logical friendliness compared to synthetic products
[8]. Plants synthesize bioactive compounds that are
responsible for in vitro antimicrobial activity of plant
extracts. These bioactive compounds include alkaloids,
flavonoids, glycosides, saponins, terpenoids, tannins,
carbohydrates and sterols [1].
The Combretaceae family has two genera and the lar-
gest and extensive genus, Combretum, consists of about
250 species distributed all through the tropics and sub-
tropics of Africa, China and India [9]. The use of Com-
bretum species in folk medicine include treatment of a
large range of ailments including headaches, abdominal
disorders, fever, gallstones, gastric ulcers, diarrhea, bil-
harzia, dysentery, hookworm, sore throat, pneumonia,
urinary tract cleaning and conjunctivitis. Phytochemical
studies on the Combretum genus have demonstrated the
presence of various classes of phytoconstituents among
them flavonoids, alkaloids, tannins and saponins [10].
Combretum zeyheri extracts have been shown inhibit
ABC-type drug efflux pumps [4], and inhibit ergosterol
synthesis in C. albicans [10].
Medicinal plants are believed to be non-toxic by
the general public. However, toxicological studies in-
dicate that they are also capable of causing numerous
side effects, and therefore, the evaluation of their
safety is warranted [11]. Cytotoxicity tests are crucial
mainly to determine potential toxicity of compounds
under study. Cytotoxicity may be determined using
primary or transformed cells [12]. It is important to
evaluate the efficacy and toxicity of plant constituents
as chemical substances in plants may have haemolytic
or anti-haemolytic effects on human red blood cells.
The evaluation of cell membrane toxicity can be car-
ried out on single cell models like erythrocytes and
liposomes [13]. The objective of the study was to
determine the toxicity of the antifungal constituents of
Combretum zeyheri on mammalian cells.
Methods
Reagents, cell cultures and animals
All chemicals used in this study were from Sigma-
Aldrich Co. (Steinheim, Germany). These included: di-
ethyl ether, ethanol, n-butanol, sodium chloride, starch,
Hank’s Balanced Salt Solution (HBSS), foetal bovine
serum (FBS), penicillin, streptomycin, RPMI 1640 pow-
der, sodium bicarbonate, trypan blue, acetic acid, ammo-
nium hydroxide, methanol, 3-(4,5-dimethylthiazol-2-yl)-
2,5-diphenyltetrazolium bromide (MTT), miconazole,
ketoconazole, dimethyl sulfoxide, Sabouraud dextrose
agar, Sabouraud dextrose broth, citric acid, sodium
citrate dihydrate, D- glucose, peptone from vegetables,
sulphuric acid, barium chloride, disodium hydrogen
phosphate, potassium dihydrogen phosphate, potassium
ferricyanide, potassium chloride, potassium cyanide, so-
dium bicarbonate and triple distilled grade water was
used for all experiments. The fungus used, Candida
albicans strain ATCC 10231 was a generous contribu-
tion from Prof K. Marobela (Department of Biological
Sciences, University of Botswana). The use of animals
and human cancer cell lines in this study was approved
by the Joint Parirenyatwa Group of Hospitals and
College of Health Sciences Research Ethics Committee
(JREC/327/14, Harare, Zimbabwe). For the toxicity stud-
ies, Jurkat-T cells were and mouse peritoneal cells were
used. Mouse peritoneal cells were extracted from 5 male
Balb/c mice and sheep erythrocytes separated from
sheep blood obtained from the Animal House, De-
partment of Anatomy, (University of Zimbabwe Mt
Pleasant, and Harare, Zimbabwe).
Plant collection and preparation of extracts
Combretum zeyheri plant leaves were collected in Nor-
ton, Mashonaland West Province of Zimbabwe, geo-
graphical coordinates: 17.8833 ° S, 30.7000 ° E, and
1364 m above sea-level. The identities of the plants were
authenticated by a botanist, Mr. Christopher Chapano,
at the National Botanic and Herbarium Garden, Harare,
Zimbabwe. Herbarium samples N6C7, were kept at the
National Botanic and Herbarium Garden (Harare,
Zimbabwe) and the Department of Biochemistry, Uni-
versity of Zimbabwe. The dried plant leaves were ground
using a two speed blender (Cole Parmer instruments
company, Vernon Hills, USA). All extractions were car-
ried out according to Mangoyi et al. [7], with a few mod-
ifications. The dried leaves of C. zeyheri were ground to
a fine powder in a blender (Philips co., Shanghai, China).
To fifty grams of powder, 500 ml of ethanol was added.
Extractions were allowed to proceed overnight. The ex-
tract were filtered using Whatman No.1 filter paper. The
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ethanol extract was dried using a rotovaporator (Rotova-
pour RII, BUCHI, Flawil, Switzerland). The extract were
collected, weighed and stored in the dark at room
temperature.
Preparation of the alkaloid-enriched fraction
Acetic acid (20 ml) in 180 ml of ethanol was added to
50 g of the powdered leaf sample, covered and left to
stand for 4 h. The mixture was filtered and the filtrate
concentrated on a water bath (Rotovapour RII, BUCHI,
Flawil, Switzerland) to 25 % its original volume.
Concentrated ammonium hydroxide was added drop by
drop to the concentrated extract until precipitation was
complete. The solution was left to settle then 9 % am-
monium hydroxide was used to wash the precipitate.
The residue was dried under a stream of air from a fan
and weighed.
Preparation of the flavonoid- enriched fraction
Fifty grams of powdered leaf sample was extracted twice
with 80 % methanol (40 ml distilled water + 160 ml
methanol) [9]. Whatman filter paper No. 1 was used for
filtration and the filtrate was evaporated on a water bath
until dry and at constant weight. Twenty grams of dried
sample was mixed with 20 % ethanol and put in an or-
bital shaker for 30 min. The mixture was heated at 55 °C
for 4 h over a water bath. The residue was re-extracted
with 20 % ethanol and filtered. The filtrate was then
extracted twice with diethyl ether, the ether layer was
discarded and the aqueous layer retained. N-butanol was
added to the aqueous layer and a pinch of sodium
chloride was added to withdraw any excess water. The
resulting solution was filtered and the filtrate oven dried
at 40 °C until a constant weight was obtained.
Preparation of a saponin-enriched fraction
The method used for the extraction was adapted from
Hostettmann et al. [14]. A mass of 50 g was weighed
and extracted in 200 mls of 70 % ethanol for 24 h and
this was done for 3 times at room temperature. The
mixture was then filtrated using Whatmann filter paper
number 1. The combined ethanol solutions were con-
centrated to a small volume using a Buchii Rotavapour
11 and extracted 3 times in succession with 200 mls
chloroform for 24 h. The resultant solution was mixed
with an equal volume of n-butanol and allowed for
solvent-solvent extraction for overnight. The n-butanol
layer was then concentrated to dryness to give the puri-
fied saponin fraction.
Preparation of C. albicans cell cultures
Sabouraud dextrose broth (SDB), was prepared and
sterilized by autoclaving. Five hundred microliters of
Candida albicans cells from glycerol stocks were
incubated in 20 ml of the media. The negative control
contained 20 ml of media. The cells were incubated at
37 °C for 24 h, in an orbital shaking incubator at
120 rpm. The cells were then cultured on Sabouraud
dextrose agar (SDA) plates. A single colony from the
agar plates was incubated in broth at 37 °C, for 24 h, in
a shaking incubator at 120 rpm (Labcon, Jeicho, Korea).
The concentration of the C. albicans cells was calculated
in relation to the 0.5 McFarland standard. The cells were
diluted to 2 × 106 cfu/ml for use in the antimicrobial
susceptibility assays.
Determination of growth inhibition parameters
Determination of growth inhibition parameters was done
using MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltet-
razolium bromide) as described by Eloff and McGaw,
[15]. Samples of the extracted phytoconstituents were
dissolved in dimethyl sulphoxide (DMSO) to make
10 mg/ml solutions which were serially diluted with
10 % DMSO then further diluted with media to give
solutions with a 2 % DMSO final concentration. Test
samples (100 μl per well) were pipetted onto round bot-
tomed 96-well plates. Cultures of the C. albicans were
transferred into fresh nutrient broth to make a 2 ×
106 cfu/ml cell suspension, 100 μl aliquots of the fresh
culture were added to the wells. The final DMSO con-
centration used in the study was 1 %. The positive con-
trol used was miconazole and an appropriate solvent
blank served as the negative control. The microplates
were incubated at 37 °C at 100 % relative humidity for
24 h. To determine cell viability, 25 μl of 2 mg/ml MTT
were added to all wells on the 96-well microplates and
incubated for three hours. MTT is converted to purple,
insoluble formazan crystals in the presence of metabolic-
ally viable cells. DMSO was used to dissolve the crystals
and the intensity of the purple colour was spectrophoto-
metrically measured at 590 nm using a microplate
reader (Tecan Genios-Pro microplate reader, Grödig,
Austria). C. albicans from the wells were sub-cultured
on agar and incubated at 37 °C for 24 h, growth
observed.
Toxicity determination using the haemolysis assay
The haemolysis assay was determined as described be-
fore [16]. A mass of 0.162 g sodium citrate was weighed
and placed in a conical flask. Sheep blood (50 ml) was
aseptically collected and placed in the flask containing
the sodium citrate. An equal volume of Alsever solution
was immediately added. The blood was centrifuged at
3000 rpm for 10 min. The supernatant was discarded
then the residue was washed three times with a 1:5 vol-
ume of phosphate buffer saline (PBS), by centrifuging at
4000 rpm for 5 min in a Hettich Rotofix 32 centrifuge
(Tuttlingen, Germany). The supernatant was discarded.
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The cells were diluted four fold with PBS and the result-
ing suspension was used for determination of haemoly-
sis. The erythrocyte suspension (500 μl) was incubated
with 500 μl of the test sample extract in phosphate
buffer saline (PBS) pH 7.2 for 90 min at 37 °C. After in-
cubation the tubes were spun in a microcentrifuge
(Hermle Z 232 M-2, Wehingen, Germany) at 3000 rpm
for 1 min. The resulting supernatant (200 μl) was added
to 3 ml of Drabkin’s reagent (0.2 mg/ml pottasium ferri-
cyanide, 0.1 mg/ml potassium cyanide and 1 mg/ml so-
dium bicarbonate). The positive control consisted of
500 μl un-centrifuged mixture of erythrocyte suspension
and 500 μl of buffer from which 400 μl was added to
3 ml Drabkin’s reagent (to obtain 100 % hemolysis). The
negative control was used to measure the level of spon-
taneous hemolysis and this was made by mixing 500 μl
of erythrocyte suspension and 500 μl of buffer, centrifu-
ging at 3000 rpm for 60s then adding 200 μl of the
supernatant to 3 ml of Drabkin’s reagent. Aliquots
(200 μl) of the supernatants in Drabkin’s reagent were
placed on round bottomed 96-well plates. To determine
the amount of haemoglobin released, the absorbance of
samples at 590 nm were read using a Tecan Genios Pro
microplate reader (Grödig, Austria). The percentage
hemolysis for each sample was calculated according to
the equation:
Percentage hemolysis ¼ ðsample absorbance=positive
control absorbanceÞ  100:
Toxicity tests on mouse peritoneal cells
To increase peritoneal cells yield, 1 ml of starch solution
(20 %) was injected intraperitoneally into 5 male Balb/c
mice (31 ± 3 g) and left for 24 h [16]. Each mouse was
euthanized by cervical dislocation. The mouse was then
sprayed with 70 % ethanol and mounted on a styrofoam
board on its back. The outer skin of the peritoneum was
cut using scissors and forceps and gently pulled, expos-
ing the inner peritoneal skin. Cold PBS with 3 % FBS
(5 ml) was injected into the peritoneal cavity taking care
not to puncture any organs. The peritoneum was then
massaged to remove any attached cells into the PBS. A
25 g needle was inserted, bevel up and attached to a
10 ml syringe in the peritoneum to collect as much fluid
as possible. The collected fluid was put into tubes kept
on ice. An incision in the inner skin was made to collect
the remaining peritoneal fluid from the cavity. Samples
with visible blood contamination were discarded. The
collected suspension was centrifuged for 10 min at
1500 rpm in a Hettich Rotofix 32 centrifuge. The super-
natant was discarded and the cells were resuspended in
RPMI and incubated overnight at 37 °C in a 5 % CO2
Shel lab incubator (CO2 series Sheldon Mfg. Inc,
Cornelius, USA). Cells were exposed to 0.4 % trypan
blue and were manually counted using a haemocytom-
eter counting chamber under a Celestron digital light
microscope (Celestron, Los-Angeles, USA) using a × 10
objective lens. The C. zeyheri ethanol extract, saponins
and alkaloids-enriched fractions were diluted such that
the lowest concentration was the IC50 for antifungal ac-
tivity and the final concentration of DMSO was 1 %.
The cells were incubated in 96-well plates in the pres-
ence of extracts for 24 h while another set of plates was
incubated for 72 h at 37 °C in a 5 % CO2 Shel lab incu-
bator (Sheldon Mfg. Inc., Cornelius, USA). Each well
contained 30 μl of the test substance, 154 μl of RPMI
and 46 μl of 0.5 × 105 cells/ml. After the 24 h the optical
density was measured on a Tecan Genios-Pro microplate
reader at 590 nm. After the 72 h incubation the cells
were stained with 0.4 % trypan blue dye and counted
using a haemocytometer counting chamber under a
Celestron digital light microscope.
Toxicity tests on Jurkat T cells
Cells stained with 0.4 % trypan blue were manually
counted using a haemocytometer counting chamber
under a Celestron digital light microscope (Celestron,
Los-Angeles, USA) to determine cell density using an
objective lens at × 10 magnification. The C. zeyheri etha-
nol extract, saponins and alkaloids-enriched fraction
were diluted such that the lowest concentration was the
IC50 for antifungal activity and the final concentration of
DMSO was 1 %. The cells plated in 96-well plates in the
presence of extracts were incubated for 48 h at 37 °C in
a 5 % CO2 Shel lab incubator. Each well contained 30 μl
of the test substance, 181 μl of RPMI and 19 μl of 1 ×
105cells/ml. After the 48 h incubation 25 μl of MTT was
added and incubated for 4 h. A volume of 50 μl DMSO
was added and optical density was measured on a Tecan
Genios-Pro microplate reader at 590 nm.
Statistical analysis
One-way analysis of variance test (ANOVA) with
Dunnett’s Multiple Comparison Post Test was used to
analyse the results. All columns of treatments were com-
pared to the control. The values with a p-value < 0.05 or
less were considered statistically significant. Graphical
and Statistical analyses were carried out using Graphpad
Prism 5® Software (Version 5.0, Graph pad Software Inc,
San Diego, USA).
Results
Extraction of plant phytoconstituents
Leaves are the phytoconstituents manufacturing site in a
plant, therefore, the phytoconstituents are found in vary-
ing amounts. For this plant leaf components, flavonoids
appear to be the most abundant phytoconstituents in
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the C. zeyheri leaves followed by alkaloids and saponins
respectively as shown in Table 1.
Antifungal activity
The antifungal activity of C. zeyheri ethanol extract, alka-
loids, flavonoids and saponins was determined by the
broth microdilution method. All extracts were shown to
possess a dose-dependent antifungal activity (Fig. 1). How-
ever, the highest concentration of 200 μg/ml, used in the
experiments was too low to obtain the MIC and MFC
values, hence, the IC50 was determined instead. The phy-
toconstituents with the lowest IC50 value and conse-
quently the greatest antifungal activity were the alkaloids,
although the crude ethanol extract had greater antifungal
activity. IC50 values are shown in Table 2. Miconazole was
used as the control drug, with an MIC of 6.25 μg/ml and
the final DMSO concentration of 1 % had no effect on C.
albicans growth as illustrated in Fig. 2.
Heamolysis assay
There was increased heamolysis as the sample concen-
tration increased. The alkaloids exhibited the greatest
hemolytic activity while, saponins were the least haemo-
lytic (Fig. 3). The EC50 is the concentrations that caused
50 % hemolysis of the sheep erythrocytes (EC50). The
ethanol extract showed an EC50 of 0.942 mg/ml, the
alkaloid-enriched fraction a value of 0.286 mg/ml, and
the saponin-enriched fraction a value 18.6 mg/ml. Thus,
the saponin –enriched fraction was the least toxic to the
erythrocytes. The varying color intensity of the lysed
erythrocytes in Fig. 4 show that hemolysis was dose-
dependent.
Effects of phytoconstituents on mouse peritoneal cells
and Jurkat T cells
Toxicity of C. zeyheri phytoconstituents was tested on
mouse peritoneal cells. All test samples were non-toxic
to the peritoneal cells. Moreover, they showed a dose-
dependent increase in mouse peritoneal cells prolifera-
tion. Additionally, the proliferation of the peritoneal cells
also increased with increasing time (Fig. 5). Similar to
the mouse peritoneal cells, the C. zeyheri constituents
promoted the growth of Jurkat T cells. The extracts were
all shown to be non-toxic to the Jurkat T cells (Fig. 6).
Discussion
Of late there was a reluctance in pursuing plants as
medicine sources due to the evolution of synthetic anti-
microbials. These synthetic drugs were effective for
some time until the sudden uprising of a number of lim-
itations to their use. Research has, thus, focused on
sources of antimicrobials from ethnobotany and ethno-
pharmacology [17]. The number of people with sup-
pressed immune systems is escalating and this has been
associated with the development of resistant fungal spe-
cies, which is the leading reason why there is need to de-
velop new effective and safe antifungals [18].
This study showed that C. zeyheri possesses antifungal
activity against Candida albicans and this is in agree-
ment with other previous studies [18–20]. The ethanol
extract, alkaloid, saponin and flavonoid-enriched frac-
tions exhibited antifungal activity. This is in agreement
with the work done by Mangoyi et al. [7], who reported
that alkaloids and saponins had anticandidal effects,
while flavonoids were not active despite them being the
most abundant phytoconstituents among those extracted
from C. zeyheri leaves. The ethanol extract was the most
active and this could be because it contains a combin-
ation of many phytoconstituents that augment each
other’s effects. Consequently, it is important to separate,
purify, identify and determine the characteristics of the
biomolecules in order to identify the compounds re-
sponsible for the antifungal activity of the plant extracts
[21]. In this study the alkaloids, flavonoids and saponins
were extracted as a preliminary step towards identifying
the specific active constituents. Indeed it has been
shown that the flavonoid 5-hydroxy-7,4’-methoxyflavone
isolated from C. zeyheri had antifungal effects [20]. The
MIC of the positive control, miconazole was as expected
and was found to be at 6.25 μg/ml. Some authors have
suggested that the sensitive concentration to miconazole
for C. albicans should be ≤ 8.0 μg/ml [22]. The solvent
used, DMSO increases membrane permeability within
the plasma membranes of cells. Other investigations
have shown that DMSO may affect cell growth, suggest-
ing that it has the ability to lessen or potentiate inhibi-
tory activities of water soluble drugs using the standard
susceptibility assays [23]. These reports necessitated the
need to investigate the effects of DMSO on C. albicans.
At a concentration of 1 %, DMSO had no growth inhibi-
tory effects on the growth of C. albicans.
The investigation of haemolytic activity is used as a
cytotoxicity measure and may be used to roughly calcu-
late therapeutic index for antimicrobials [24]. Determin-
ation of hemolysis activity is an alternative screening
process for evaluating simple toxicity. It is quick, repro-
ducible and cheap to carry out, enabling the reduction
of laboratory animals for in vivo studies, therefore, redu-
cing, refining and replacing studies carried out on
Table 1 Mass and percentage yield of the extracted samples
from Combretum zeyheri leaves
Sample Mass Percentage yield
Flavonoids 5.341 g 10.68 %
Ethanol extract 3.106 g 6.212 %
Alkaloids 1.562 g 3.124 %
Saponins 0.082 g 0.410 %
The masses are from a starting sample of 50 g of the leaf extracts. The
percentage yield was calculated as a percentage of the starting mass
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animals [25]. Hemolysis is a result of membrane lipid bi-
layer lysis causing red blood cell destruction [26].
Haemolytic activity of the C. zeyheri constituents was
shown to be concentration-dependent. This is in
agreement with the work produced by Noudeh et al.
[13] who showed that hemolytic activity increases with
increasing extract concentration based on Fick’s law.
Diffusion flux from a membrane is proportional to dif-
ferences in concentration on both sides, therefore, in-
creasing extract concentration in the extra membrane
causes the extract to diffuse to the intra membrane until
it gets to a certain concentration, leading to membrane
damage and hemolysis. It should be noted that the
haemolytic activity of an extract depends on chemical
composition of the extract as illustrated by the different
haemolytic activities of the C. zeyheri ethanol extract, al-
kaloid and saponin-enriched fractions. The alkaloid-
enriched fraction showed the most haemolytic effects
followed by the crude ethanol extract and the saponin-
enriched fraction showed the least haemolytic activity.
Although the ethanol extract possibly contains various
phytoconstituents, it had a lesser haemolytic effect than
the alkaloid-enriched fraction. We suggest that the crude
ethanol extract may contain other phytoconstituents that
are anti-haemolytic. Inalegwu and Sodipo, [27] indicated
that the haemolytic activity of crude extracts can be
attributed to saponin content. In contract in this study,
saponins had the least haemolytic effect. Noudeh et al.
[13], however, pointed out that although saponins natur-
ally possess cell membrane permeabilising activity, their
haemolytic activity depends on the chemical compos-
ition. Triterpenoid aglycon saponins are less haemolytic
compared to saponins with steroidal aglycons. It is,
therefore, plausible to suggest that the C. zeyheri sapo-
nins might possess the triterpenoid aglycons. Compared
to the IC50 values, the haemolysis effective concentration
A B
C D
Fig. 1 Antifungal effects of C. zeyheri extracts on C. albicans growth, where (a) is the ethanol extract, (b) the alkaloid-enriched fraction, (c) the
saponin-enriched fraction and (d) the flavonoid-enriched fraction. Concentrations are in μg/ml and asterisks represent growth that is significantly
different from the control (* = p < 0.5, ** = p < 0.001 and *** = p < 0.0001) ANOVA with Dunnet’s multiple comparison test. Values are for mean ±
SD for n = 4. Percentage values on highest concentration indicate percentage decrease in C. albicans growth
Table 2 MIC and IC50 values determined for the phytochemical
constituents
Sample MIC IC50
Ethanol extract - 16 μg/ml
Alkaloid-enriched fraction - 20 μg/ml
Saponin-enriched fraction - 100 μg/ml
Flavonoid-enriched fraction - 159 μg/ml
Miconazole 6.25 μg/ml 1.1 μg/ml
The IC50 was determined as the concentration that caused a reduction in 50 %
of the growth based on the absorbance value at 590 nm of the positive
growth control sample. The minimum inhibitory concentration (MIC) is the
lowest concentration of an antimicrobial that will inhibit the visible growth of
a microorganism. (-) indicates that no MIC was obtained
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(EC50) values of the potent phytoconstituents were much
higher, thus, giving a large therapeutic window for the
constituents as reported by Cherion et al. [28]. In this
study, alkaloids were shown to have the greatest
hemolytic activity but with a lower antifungal activity
against C. albicans, compared to the ethanol extract. It
may be suggested that use of an ethanol extract in anti-
fungal treatment is better because once there is separ-
ation of the whole extract to phytoconstituents, there
would be decreased antifungal activity, while simultan-
eously increasing haemolysis for some of the phytocon-
stituents, notably the alkaloids.
First line immunological defense versus bacterial, fun-
gal and viral infections and tumour cells involves macro-
phages and natural killer (NK) cells. Macrophages also
present antigens to lymphocytes during specific immun-
ity development and in addition release factors that aid
lymphocyte activity [29]. The peritoneal cavity in the
A
B
Fig. 2 The effects of (a) miconazole and (b) solvent DMSO on C.
albicans growth. Asterisks represent growth that is significantly different
from the control (* = p< 0.5, ** = p< 0.001 and *** = p< 0.0001) ANOVA
with Dunnet’s multiple comparison test. Values are for mean ± SD for
n= 4. Percentage values on highest concentrations indicate the
percentage decrease in C. albicans growth
Fig. 3 The hemolysis of sheep erythrocytes induced by exposure to the ethanol extract, alkaloid and saponin –enriched fraction. A plot of log
EC50 versus percentage hemolysis were used to determine the concentration of the extract that caused a 50 % reduction in hemolysis. The
percentage hemolysis for each sample was calculated according to the equation: Percentage hemolysis = (sample absorbance/positive control
absorbance) × 100. Values are for mean ± SD for n = 6
Fig. 4 Image showing a 96-well plate for hemolysis of sheep erythro-
cytes exposed to C. zeyheri ethanol extract, alkaloid-enriched fraction
and saponin-enriched fraction. The negative control (−ve ctrl), was a
measure of spontaneous hemolysis and contained PBS and erythro-
cytes only, in Drabkin’s reagent and the positive control (+ve ctrl)
which shows 100 % hemolysis was obtained by mixing un-centrifuged
erythrocytes in PBS with Drabkin’s reagent
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abdomen of mammals is membrane bound and filled
with fluid, in which the gastrointestinal tract, spleen and
liver are housed. It is also a favourable site for the collec-
tion of naïve macrophages because they are found in
large numbers. Peritoneal cavity cells are ideal for use in
studies pertaining to different immune cells particularly
macrophages [30]. The C. zeyheri ethanol extract, alkal-
oid and saponin-enriched fractions were not toxic to the
mouse peritoneal cells but instead promoted the growth
and survival of these cells. The extracts could be acting
as antigens which may be triggering an immune re-
sponse, hence, the mouse peritoneal cells’ proliferation.
This is in agreement with the work of Bukowski et al.
[31], who showed that immune system cells, specifically
T lymphocytes can proliferate when exposed to some
antigenic alkylamines. These alkylamines are mostly
found in bacterial supernatants but are also present in
some plants for example as tea and apple constituents.
There is a possibility that C. zeyheri leaf extracts contain
these substances. Other plant extracts, for example Ko-
rean mistletoe lectin, were also shown to increase peri-
toneal macrophages and splenic natural killer cells’
activity [29]. This activity was shown to be related to
their in vivo action of the immune system, where lectin
treatment increased the number of macrophages and
lymphocytes in the peritoneal cavity of mice [32]. Al-
lium sativum extracts enhance immune function by
increasing the number of macrophages and T lym-
phocytes [33, 34]. Extracts from A. precatorius were
also found to be non-toxic to mouse peritoneal mac-
rophages [35]. Leaf extracts from C. zeyheri can, thus,
are, thus, non-toxic to mouse peritoneal cells. Their
growth-enhancing effect would be beneficial to im-
munocompromised patients if taken as herbals from
C. zeyheri since the extract would act as an antifungal
and immunity booster at the same time.
Jurkat cells are a cancer cell line which was established
from the peripheral blood of a 14 year old boy who had
T cell leukaemia [36]. These cells allow for in vitro test-
ing in studies as they are capable of being cultured and
proliferate under appropriate conditions [37]. There was
no toxicity reported when Jurkat T cells were exposed to
C. zeyheri ethanol extract, alkaloid and saponin-enriched
fractions. Similar results were obtained when Jurkat T
cells were exposed to the hexane leaf extract of D. cauli-
florum, which was found to be non-toxic to the Jurkat T
cells [38]. Mozonte et al. [39] also reported that the
ethanol bark extract of Q. insignis and the methanol
bark extract of Canostelgia xalapensis were non-toxic to
both Balb/c mouse macrophages and human tumour
cells. This is in agreement with the results obtained in
this study, where C. zeyheri extracts were non-toxic to
both Balb/c mouse peritoneal cells and Jurkat T cells, a
human cancer cell line. Jurkat T cells, being transformed
white blood cells may have been stimulated to grow in
order to boost immunity just like the mouse peritoneal
cells. The extracts from C. zeyheri, may, therefore, be
contraindicated in leukaemic patients as they will prob-
ably encourage growth of the cancerous cells. The alka-




Fig. 5 The effects of C. zeyheri (a) ethanol extract, (b) alkaloid-enriched
fraction and (c) saponin-enriched fraction on mouse peritoneal cells.
The graphs are a comparison of the cell density measured at 590 nm
after 24 and 72 h of incubation Concentrations are in μg/ml. Values are
for mean ± SD for n = 24
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not-toxic to Jurkat T cells and mouse peritoneal cells,
but actually enhanced their growth. Extrapolation of the
results to in vivo situation may suggest that whilst the
plant extracts have antifungal effects, they may also
increase the proliferation of the immune cells, thus pro-
viding enhanced fungicidal effects on the fungal patho-
gens. Although these extracts caused hemolysis of sheep
erythrocytes, there was a large magnitude of difference
between the IC50 values and the hemolysis EC50 values,
implying a large therapeutic window.
Conclusions
We conclude that the antifungal and non-toxic charac-
teristics of the C. zeyheri ethanol extract, alkaloid, and
saponin-enriched fractions makes these constituents
strong candidates for the isolation of the antifungal ac-
tive compounds. These compounds can then serve as
templates in antifungal drug development after being
modified to remove functional groups that could be re-





Fig. 6 The effects of C. zeyheri, (a) alkaloid-enriched fraction, (b) ethanol extract and (c) saponin-enriched fraction on Jurkat T cells. A comparison
of the cell density at 590 nm in the absence and presence of an extract. Concentrations are in μg/ml. Values are for mean ± SD for n = 24
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